🔎 Trials Near Me

Home › Anxiety › NCT05789446

Confirmatory Efficacy of the Building a Strong Identity and Coping Skills Program

RecruitingHealthy volunteers welcome

Confirmatory Efficacy of the Building a Strong Identity and Coping Skills Program for Low-income and Minoritized Young Adolescents

Who can join

Ages 11 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Children ages 11-14 at intake
* Family income at or below 200% federal poverty level
* Child speaks English
* Parent speaks English or Spanish

Exclusion Criteria:

* Intellectual disability
* Autism spectrum disorder
* High suicidal risk (score of 17 or more on the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-Kid))
* Severe depression (score of 19 or more on Patient health questionnaire (PHQ).

About the study

The goal of this clinical trial is to the efficacy of the Building a Strong Identity and Coping Skills intervention within a sample of low-income and minoritized youth aged 11-14 who are seeking mental health treatment and have been placed on a waitlist to receive services.

The aims of this study are to: (1) confirm the efficacy of BaSICS by replicating previous findings, (2) Examine the changes of coping mechanisms and symptom change over the course of the BaSICS intervention, and (3) test models of physiologic stress reactivity and regulation to capture biological "risk" and recalibration.

Cohorts of 20 participants will randomly be enrolled in either the intervention (10) or control (10) groups. Participants enrolled in the intervention group will complete the BaSICS program and participants enrolled in the no intervention group will not be enrolled in the intervention program. The BaSICS program is designed to help treat anxiety, depression, and post-traumatic stress symptoms and disorders and have direct effects on physiologic stress response systems (hypothalamic-pituitary-adrenal (HPA) axis). Researchers will compare the intervention and no intervention groups to see if there is a difference in the reduction of markers for anxiety, depression, and suicide scores, changes in coping mechanism, and HPA reactivity profiles

What is being tested

Sponsor: Penn State University · Participants: 360 · Started: Feb 1, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT05789446

Locations in the U.S.

PennsylvaniaPennsylvania Psychiatric Institute, Harrisburg (Not yet recruiting)
Penn State Health Medical Group - Psychiatry and Behavioral Health, Hershey
Penns Valley Area School District, Spring Mills (Not yet recruiting)
Dr. Edwin L. Herr Clinic, State College
Penn State Psychological Clinic, State College

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.